Skip to main content

Table 3 The socio-behavioural, clinical and HIV-related factors associated with anogenital warts

From: Prevalence of anogenital HPV infection, related disease and risk factors among HIV-infected men in inner-city Johannesburg, South Africa: baseline findings from a cohort study

Characteristic AGW detected
N = 36
n (%) or mean (SD)
M 1 (Crude)
OR (95% CI)
p-value M2 a
OR (95%CI)
p-value
Born in SA 27 (75) 1.44 (0.65–3.20) 0.36 1.60 (0.71–3.58) 0.25
Marital status (Single) 29 (80) 2.00 (0.83–4.81) 0.12 1.71 (0.69–4.21) 0.24
Employed 26 (72) 1.20 (0.54–2.67) 0.66 1.02 (0.45–2.30) 0.97
Currently smokes 12 (33) 1.13 (0.54–2.38) 0.74 1.16 (0.55–2.44) 0.70
Currently drinks alcohol 20 (56) 1.18 (0.58–2.41) 0.65 1.09 (0.53–2.24) 0.82
Age at sexual debut 18 (3) 0.99 (0.89–1.11) 0.91 1.00 (0.89–1.13) 0.93
Ever had sex with men 1 (3) 0.52 (0.07–4.06) 0.53 0.48 (0.06–3.80) 0.49
> 1 sexual partners in past 3 months 8 (22) 0.89 (0.38–2.04) 0.78 0.82 (0.35–1.92) 0.65
Consistent condom use with recent partner 25 (69) 1.81 (0.52–6.31) 0.35 2.16 (0.61–7.70) 0.23
Circumcised 3 (8) 0.32 (0.10–1.09) 0.06 0.33 (0.09–1.13) 0.07
On ART 26 (72) 1.47 (0.68–3.19) 0.32 2.19 (0.94–5.07) 0.07
Duration on ART (months)
  > 12 14 (39) 1   1  
 6–12 8 (22) 4.03 (1.50–10.81) 0.006 3.54 (1.29–9.72) 0.01
  < 6 4 (11) 8.06 (1.94–33.50) 0.004 6.90 (1.63–29.20) 0.009
CD4+ count (cells/μL)
  > 500 7 (19) 1   1  
 351–500 10 (28) 1.72 (0.63–4.71) 0.29 1.62 (0.58–4.49) 0.93
 200–350 12 (33) 3.68 (1.36–9.95) 0.01 4.34 (1.57–12.07) 0.01
  < 200 6 (17) 4.32 (1.32–14.25) 0.02 5.48 (1.60–18.78) 0.01
Undetectable PVL (<40 copies/ml) 11 (31) 0.65 (0.31–1.39) 0.26 0.77 (0.35–1.68) 0.51
Controlled HIV diseaseb 3 (8) 0.25 (0.08–0.85) 0.03 0.22 (0.12–0.79) 0.02
Cytological abnormalities 10 (28) 0.67 (0.29–1.55) 0.35 0.67 (0.29–1.59) 0.37
  1. M2a: Adjusted for age. PVL plasma viral load. b: On ART for >6 months, CD4+ > 350 and undetectable PVL